Hans Hull

Affiliations

  • Chief Business Officer at Pliant Therapeutics Inc. (PLRX), 2025-01-27
  • Chief Executive Officer at Avalanche Biotechnologies Inc. (AAVL), 2015-08-25
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
PLRX $11.20 15,936 $178,500.73 211,558 2025-01-17 Filing
PLRX $11.56 9,900 $114,444.00 227,494 2024-07-10 Filing
PLRX $17.23 9,786 $168,612.78 185,069 2024-01-17 Filing
PLRX $20.01 20,050 $401,200.50 194,855 2023-08-04 Filing
PLRX $20.00 1,800 $36,000.00 206,114 2023-08-03 Filing